Fukuyama Transporting (9075) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
13 Jul, 2026Executive summary
Net sales for the nine months ended December 31, 2025, rose 4.7% year-over-year to ¥239,518 million, with operating profit up 2.8% to ¥8,706 million and profit attributable to owners of parent surging 47.4% to ¥14,222 million.
Comprehensive income increased significantly to ¥13,132 million, up 1,402.8% year-over-year.
Financial highlights
Gross profit for the nine-month period was ¥16,040 million, up from ¥15,475 million year-over-year.
Ordinary profit declined 3.3% year-over-year to ¥10,551 million.
Basic earnings per share increased to ¥380.58 from ¥239.43 year-over-year.
Net assets as of December 31, 2025, were ¥288,858 million, with an equity-to-asset ratio of 56.1%.
Cash and cash equivalents at period end were ¥30,643 million, up from ¥29,626 million at the start of the period.
Outlook and guidance
Full-year forecast for fiscal year ending March 31, 2026: net sales ¥316,300 million (+4.6% YoY), operating profit ¥8,100 million (+10.0% YoY), ordinary profit ¥9,700 million (−2.2% YoY), profit attributable to owners of parent ¥13,000 million (+48.6% YoY), and basic EPS ¥352.59.
No revisions to previously announced earnings or dividend forecasts.
Latest events from Fukuyama Transporting
- Net sales rose 5.2% while profit attributable to owners increased 11.7% year-over-year.9075
Q4 202513 Jul 2026 - Strong profit growth and positive outlook, with notable extraordinary gains and treasury share buybacks.9075
Q4 202613 Jul 2026 - Net sales grew 4.6% year-over-year, but profit attributable to owners fell 44.3%.9075
Q2 202613 Jul 2026 - Sales rose but profits declined; full-year outlook expects lower earnings despite revenue growth.9075
Q3 202513 Jul 2026 - Sales rose but profits declined; full-year outlook expects lower earnings despite higher revenue.9075
Q2 202513 Jul 2026 - Sales up 5%, profits down, but full-year outlook anticipates strong earnings recovery.9075
Q1 202613 Jul 2026 - Net sales grew, but profits declined and comprehensive income turned negative on valuation losses.9075
Q1 202513 Jul 2026